Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT01759420
Eligibility Criteria:
Inclusion Criteria:
* Age \>18
* Patient to receive 4mg of intravenous ondansetron
Exclusion Criteria:
* Age \<18
* known long QT syndrome
* received oral or intravenous ondansetron within 4 hours of enrollment
* co-administration of any known QT prolonging agents
* QTc on baseline of \>450 ms for males and \>470ms for females
* allergy or known hypersensitivity to ondansetron
* altered mental status
* non-sinus rhythm on baseline EKG
* hypokalemia (as defined by the lower limit of normal for the reference laboratory)
* hypomagnesemia (as defined by the lower limit of normal for the reference laboratory)
* any presentation for chest pain with signs of ischemia on baseline EKG
* QRS duration \> 120 msec
* bundle branch block (right or left)
* ventricular pre-excitation or signs of left ventricular hypertrophy with repolarization abnormalities
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01759420
Study Brief:
Protocol Section:
NCT01759420